Search research articles
Contact Us
Filters
Showing results (151-160 of 156) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 156 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Interlaboratory evaluation of a new reverse transcriptase polymerase chain reaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: a multicenter study of the Dermatologic Cooperative Oncology Group
U Reinhold, C Berkin, A K Bosserhoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
K Spieth, R Kaufmann, R Dummer, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 22, 2003
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]
F Mornex, L Thomas, P Mohr, et al.
Melanoma Research
|
February 6, 2003
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma
F Mornex, L Thomas, P Mohr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
M R Middleton, J J Grob, N Aaronson, et al.
Journal of Medical Genetics
|
February 4, 2005
Mutational spectrum of NSDHL in CHILD syndrome
D Bornholdt, A König, R Happle, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 156) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 156 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Interlaboratory evaluation of a new reverse transcriptase polymerase chain reaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: a multicenter study of the Dermatologic Cooperative Oncology Group
U Reinhold, C Berkin, A K Bosserhoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
K Spieth, R Kaufmann, R Dummer, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 22, 2003
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]
F Mornex, L Thomas, P Mohr, et al.
Melanoma Research
|
February 6, 2003
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma
F Mornex, L Thomas, P Mohr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
M R Middleton, J J Grob, N Aaronson, et al.
Journal of Medical Genetics
|
February 4, 2005
Mutational spectrum of NSDHL in CHILD syndrome
D Bornholdt, A König, R Happle, et al.
Page
of 16